Industry Portals
Chemical Industry News
Integer a velit nec risus malesuada imperdiet id et odio. Nunc sit amet mauris dapibus, feugiat diam eget, suscipit, nam gravida nulla eget turpis commodo.
Chemical Executives Deal with Tariffs (ICIS Chemical Business May 9 – May 15, 2025)
ICIS Chemical Business reports on panel discussion (Apollo, Dow and Westlake executives) moderated by Peter Young on April 30, 2025.
Young & Partners Forum Series: How to Build an Effective Salesforce – Adam Woodrow of Paratek Pharmaceuticals
Adam Woodrow, President and Chief Commercial Officer, Paratek Pharmaceuticals Peter Young, President and CEO, Young & Partners
Young & Partners Forum Series: Drug Innovation Insights – Lessons From History – William Pao of Revelio Therapeutics
William Pao, CEO of Revelio Therapeutics and Former Chief Development Officer and Executive Vice President for Pfizer Peter Young, President and CEO, Young & Partners
Chemical Debt Financing Perks Up (ICIS Chemical Business February 21 – February 27, 2025)
Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have rebounded chemical debt financings and the outlook for 2025.
Biopharma Business Check – Financing and Review (Pharmaceutical Executive, February 2025)
Young & Partners shares proprietary analysis of the stock market and funding environment in Biotech and Pharma and the outlook for 2025.
Global M&A Treads Water
Young & Partners shares proprietary analysis of the Chemicals M&A market and their outlook for 2025.
Divestitures in the Current Environment
Young & Partners shares proprietary analysis of the Chemicals M&A market and proposes questions for Chemicals owners to think over as significant asset rationalization occurs globally.
Reflections on 2024 and Outlook – Stock Market and Funding
Young & Partners shares proprietary analysis of the stock market and funding environment in Biotech and Pharma and the outlook for 2025.
Reflections on 2024 and Outlook – Senior Management Approach to M&A
Young & Partners shares proprietary analysis and outlook of how managers and executive should approach Biotech and Pharma M&A market in 2025.
Reflections on 2024 and Outlook – Biotech and Pharma M&A
Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have affected the Biotech and Pharma M&A market in 2024 and the outlook for 2025.
Young & Partners 2024 Chemical Conference: Speakers Roundtable- What Does the Future Hold?
Joe Chang, Global Editor, ICIS Chemical Business Stephen Floyd, Managing Director, Young & Partners Dewey Johnson, SVP Chemical Market Analytics Lien-Hang T. Nguyen, Director of the Weatherhead East Asian Institute, Columbia University Charlie Vest, Associate Director, China Practice, Rhodium Group Peter Young, President and CEO, Young & Partners
Young & Partners 2024 Chemical Conference: Dewey Johnson: Global Energy & Chemical Markets – Emerging from the Trough
Dewey Johnson, SVP Dow Jones, Global Lead Chemical Market Analytics
Young & Partners 2024 Chemical Conference: Perspectives on Asia and the Middle East and the Impact on Chemicals
Dewey Johnson, SVP & Global Lead, Chemical Market Analytics Lien-Hang T. Nguyen, Director of the Weatherhead East Asian Institute, Columbia University Charlie Vest, Associate Director, China Practice, Rhodium Group Peter Young, President & CEO, Young & Partners
Young & Partners 2024 Chemical Conference: Joe Chang: The Current Challenges and the Future State of the Chemical Industry
Joe Chang, Global Editor, ICIS Chemical Business Peter Young, President and CEO, Young & Partners
Young & Partners Pharmaceutical Executive Summit 2024: The Impact of Artificial Intelligence on the Creation of Medicines (Pharmaceutical Executive)
Pharmaceutical Executive shares Fred Hassan's and Najat Khan's comments made at the 2024 Young & Partners Pharmaceutical Executive Summit. https://www.pharmexec.com/view/young-partners-pharmaceutical-executive-summit-2024-impact-artificial-intelligence-creation-medicines
Young & Partners 2024 Pharmaceutical Executive Summit: Speakers Roundtable- What Does the Future Hold
Michael Christel, Global Editor, MJH Life Sciences; Fred Hassan, Director, Warburg Pincus; Najat Khan, Chief R&D and Commercial Officer, Recursion; Doug Long, Vice President, Industry Relations, IQVIA; Peter Marks, M.D., Director, Center of Biologics Evaluation and Research, U.S. Food and Drug Administration; Dr. Stephen P. Spielberg, M.D. PhD, Senior Adviser, Young & Partners, former Deputy Commissioner for Medical Products and Tobacco, U.S. Food and Drug Administration; Sandy Zweifach, President and CBO, IMIDomics; Peter Young, CEO and President, Young & Partners
Young & Partners 2024 Pharmaceutical Executive Summit: Michael Christel and Sandy Zweifach- The Changing Roles and Relationships of Biotech and Pharma
Michael Christel, Global Editor, MJH Life Sciences; Sandy Zweifach, President and CBO, IMIDomics
Young & Partners 2024 Pharmaceutical Executive Summit: Fred Hassan and Najat Khan- The Impact of Artificial Intelligence on the Creation of Medicines
Fred Hassan, Director, Warburg Pincus; Najat Khan, Chief R&D and Commercial Officer, Recursion
Young & Partners 2024 Pharmaceutical Executive Summit: Doug Long: The Pharmaceutical Market: Trends, Issues and Outlook
Doug Long, Vice President, Industry Relations, IQVIA Holdings Inc.